NASDAQ:BCYC

Bicycle Therapeutics Stock Forecast

etoro logo Buy BCYC
*Your capital is at risk
$4.03
-0.140 (-3.36%)
At Close: Jun 10, 2026
AI Analysis AI Analysis of BCYC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BCYC to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Bicycle Therapeutics PLC stock downgraded from Sell Candidate to Strong Sell Candidate after Wednesday trading session
(Updated on Jun 10, 2026)

Sell candidate since May 07, 2026 Loss -17.59%

The Bicycle Therapeutics PLC stock price fell by -3.36% on the last day (Wednesday, 10th Jun 2026) from $4.17 to $4.03. During the last trading day the stock fluctuated 5.34% from a day low at $4.03 to a day high of $4.24. The price has fallen in 6 of the last 10 days and is down by -11.82% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -433 thousand shares and in total, 237 thousand shares were bought and sold for approximately $956.94 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.89 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.44% during the next 3 months and, with a 90% probability hold a price between $3.52 and $4.55 at the end of this 3-month period.

BCYC Signals & Forecast

There are few to no technical positive signals at the moment. The Bicycle Therapeutics PLC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.18 and $4.59. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 17, 2026, and so far it has fallen -24.39%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Bicycle Therapeutics PLC stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.215 between high and low, or 5.34%. For the last week the stock has had daily average volatility of 4.63%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCYC) For The Upcoming Trading Day Of Thursday 11th

For the upcoming trading day on Thursday, 11th we expect Bicycle Therapeutics PLC to open at $4.10, and during the day (based on 14 day Average True Range), to move between $3.93 and $4.13, which gives a possible trading interval of +/-$0.198 (+/-5.03%) up or down from last closing price. If Bicycle Therapeutics PLC takes out the full calculated possible swing range there will be an estimated 5.03% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $4.35, some $0.320 (7.94%) from the current price of $4.03, our system finds the risk reward not very attractive.

Is Bicycle Therapeutics PLC stock A Buy?

Bicycle Therapeutics PLC holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.149 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 11, 2026 - $4.10 ( 1.70%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BCYC Performance

Trading levels for BCYC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.31 7.03%
R2 4.23 4.99%
R1 4.18 3.73%
Price 4.03
S1 4.02 -0.342%
S2 3.97 -1.60%
S3 3.88 -3.64%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.90 21.59%
R2 4.50 11.66%
R1 4.35 7.94%
Price 4.03
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Bicycle Therapeutics PLC Stock and on which exchange is it traded?
The symbol for Bicycle Therapeutics PLC is BCYC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bicycle Therapeutics PLC Stock.

What's the current price of Bicycle Therapeutics PLC Stock?
As of the end of day on the Jun 10, 2026, the price of an Bicycle Therapeutics PLC (BCYC) share was $4.03.

What is the 52-week high and low for Bicycle Therapeutics PLC Stock?
The 52-week high for Bicycle Therapeutics PLC Stock is $9.36 and the 52-week low is $3.99.

What is the market capitalization of Bicycle Therapeutics PLC Stock?
As of the Jun 10, 2026, the market capitalization of Bicycle Therapeutics PLC is 279.66M.

When is the next earnings date for Bicycle Therapeutics PLC?
The upcoming earnings date for Bicycle Therapeutics PLC is Aug 14, 2026.
Click to get the best stock tips daily for free!
ABOUT BICYCLE THERAPEUTICS PLC
Bicycle Therapeutics
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial ...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE